Impurities are any components that are not active ingredients or excipients, and that can compromise quality in a drug substance or product. Pharmaceutical impurities can be classified as organic or inorganic and include residual solvents. The presence of impurities results from manufacturing and degradation processes.

Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines

This spring, long-time USP volunteer Dennis Gorecki, Ph.D., became the latest recipient of USP’s signature Beal Award for outstanding contributions to public health while serving as a USP volunteer.